Marginal donors and organ shortness: concomitant surgical procedures during heart transplantation: a literature review.


Journal

Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752

Informations de publication

Date de publication:
01 03 2022
Historique:
pubmed: 23 8 2021
medline: 15 3 2022
entrez: 22 8 2021
Statut: ppublish

Résumé

Heart transplantation represents the gold standard for end-stage heart failure. However, due to the increasing demand and the shortage of available organs, donor supply remains the main limitation. Marginal donor hearts in high-risk candidates who do not meet standard listing criteria are the only alternative when life expectancy is limited, but their use is still debated. Surgical correction of detected coronary lesions or valvular heart defects allows further enlargement of the number of available organs. In this article, we offer a literature review on this topic and report two marginal donor hearts with angiography evidence of coronary stenosis and preserved ventricular function, which underwent concomitant myocardial revascularization during heart implantation.

Identifiants

pubmed: 34420009
doi: 10.2459/JCM.0000000000001233
pii: 01244665-202203000-00004
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-175

Informations de copyright

Copyright © 2021 Italian Federation of Cardiology - I.F.C. All rights reserved.

Références

Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 2017; 136:137–161.
Thomson DJ, Kostuk W, Pflugfelder P, Menkis A, McKenzie FN. De novo coronary artery grafting in a heart transplant recipient. J Heart Transplant 1988; 7:468–470.
Laks H, Gates RN, Ardehali A, et al. Orthotopic heart transplantation and concurrent coronary bypass. J Heart Lung Transplant 1993; 12:810–815.
Pinto CS, Prieto D, Antunes MJ. Coronary artery bypass graft surgery during heart transplantation. Interact Cardiovasc Thorac Surg 2013; 16:224–225.
Rao JN, Prendergast B, Dark JH. Orthotopic heart transplantation with concurrent aortic valve replacement and coronary artery bypass grafting. J Heart Lung Transplant 2000; 19:897–899.
Abid Q, Parry G, Forty J, Dark JH. Concurrent coronary grafting of the donor heart with left internal mammary artery: 10-year experience. J Heart Lung Transplant 2002; 21:812–814.
Marelli D, Laks H, Bresson S, et al. Results after transplantation using donor hearts with preexisting coronary artery disease. J Thorac Cardiovasc Surg 2003; 126:821–825.
Musci M, Pasic M, Grauhan O, et al. Orthotopic heart transplantation with concurrent coronary artery bypass grafting or previous stent implantation. Z Kardiol 2004; 93:971–974.
Yang HS, Chen IC, Lee YT, et al. Cardiac transplantation and concomitant coronary artery bypass grafting: our experiences in 11 cases. Transplant Proc 2014; 46:900–902.
Burnett CM, Radovancević B, Birovljev S, et al. Concomitant donor heart coronary artery bypass grafting during orthotopic heart transplantation. Texas Heart Inst J 1990; 17:126–128.
Risher WH, Ochsner JL, Van Meter C. Cardiac transplantation after donor mitral valve commissurotomy. Ann Thorac Surg 1994; 57:221–222.
Antunes PE, Prieto D, Eugénio L, Antunes MJ. Donor mitral valve repair in cardiac transplantation. J Thorac Cardiovasc Surg 2005; 129:227–228.
Massad MG, Smedira NG, Hobbs RE, Hoercher K, Vandervoort P, McCarthy PM. Bench repair of donor mitral valve before heart transplantation. Ann Thorac Surg 1996; 61:1833–1835.
Michler RE, Camacho DR. Ex-vivo mitral valve repair prior to orthotopic cardiac transplantation. Ann Thorac Surg 2002; 73:962–963.
Okamura H, Woo YJ. Ex vivo allograft mitral valve leaflet repair prior to orthotopic heart transplantation. J Card Surg 2014; 29:424–426.
Pawale A, Tang GH, Milla F, Pinney S, Adams DH, Anyanwu AC. Bench mitral valve repair of donor hearts before orthotopic heart transplantation. Circ Heart Fail 2012; 5:96–97.
Prieto D, Antunes P, Antunes MJ. Donor mitral valve repair in cardiac transplantation. Transplant Proc 2009; 41:932–934.
Sprengel A, Skwara W, Ziegelhöffer T, Cetinkaya A, Schönburg M, Richter M. Combined mitral valve repair and heart transplantation. Clin Case Rep 2018; 6:564–568.
Fiore A, Grande AM, Gatti G, et al. Valvular surgery in donor hearts before orthotopic heart transplantation. Arch Cardiovasc Dis 2020; 113:674–678.
Larobina ME, Mariani JA, Rowland MA. Aortic valve replacement for aortic stenosis during orthotopic cardiac transplant. Ann Thorac Surg 2008; 86:1979–1982.
Globits S, De Marco T, Schwitter J, et al. Assessment of early left ventricular remodeling in orthotopic heart transplant recipients with cine magnetic resonance imaging: potential mechanisms. J Heart Lung Transplant 1997; 16:504–510.
Patel M, Vahdat KK, Nathan S, et al. Bioprosthetic aortic valve replacement in a donor heart before orthotopic heart transplantation. Tex Heart Inst J 2017; 44:135–137.
Jeevanandam V, Russell H, Mather P, et al. A one-year comparison of prophylactic donor tricuspid annuloplasty in heart transplantation. Ann Thorac Surg 2004; 78:759–766.
Jeevanandam V, Russell H, Mather P, Furukawa S, Anderson A, Raman J. Donor tricuspid annuloplasty during orthotopic heart transplantation: long-term results of a prospective controlled study. Ann Thorac Surg 2006; 82:2089–2095.
Fiorelli AI, Stolf NA, Abreu Filho CA, et al. Prophylactic donor tricuspid annuloplasty in orthotopic bicaval heart transplantation. Transplant Proc 2007; 39:2527–2530.
Brown NE, Muehlebach GF, Jones P, Gorton ME, Stuart RS, Borkon AM. Tricuspid annuloplasty significantly reduces early tricuspid regurgitation after biatrial heart transplantation. J Heart Lung Transplant 2004; 23:1160–1162.
de Beco G, Duisit J, Poncelet AJ. Heart transplantation using a donor with partial anomalous pulmonary venous connection and atrial septal defect. Interact Cardiovasc Thorac Surg 2017; 24:978–979.
Vigneswaran WT, Edwards BS, McGregor CG. Extended donor use for heart transplantation. Ann Thorac Surg 1993; 56:552–553.
Maltais S, Carrier M, Pellerin M, Perrault LP. Closure of ventricular septal defects in the donor heart before transplantation: toward expanded acceptance criteria. J Thorac Cardiovasc Surg 2005; 129:1187–1188.
Pradegan N, Toscano G, Gerosa G. Mending hearts: a further strategy to improve cardiac donors availability. J Card Surg 2021; 36:2989–2991.
Felker GM, Milano CA, Yager JE, et al. Outcomes with an alternate list strategy for heart transplantation. J Heart Lung Transplant 2005; 24:1781–1786.
Trivedi JR, Cheng A, Singh R, Williams ML, Slaughter MS. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant. Ann Thorac Surg 2014; 98:830–834.
Gao HZ, Hunt SA, Alderman EL, Liang D, Yeung AC, Schroeder JS. Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease. J Am Coll Cardiol 1997; 29:623–629.
Wong CK, Yeung AC. The topography of intimal thickening and associated remodelling pattern of early transplant coronary disease: influence of preexistent donor atherosclerosis. J Heart Lung Transplant 2001; 20:858–864.
Schmack B, Weyman A, Mohite P, et al. Contemporary review of the organ care system in lung transplantation: potential advantages of a portable ex-vivo lung perfusion system. Expert Rev Med Devices 2016; 13:1035–1041.
Ardehali A, Esmailian F, Deng M, et al. for the PROCEED II trial investigators ∗ . Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised noninferiority trial. Lancet 2015; 9987:2577–2584.
Marelli D, Laks H, Fazio D, Moore S, Moriguchi J, Kobashigawa J. The use of donor hearts with left ventricular hypertrophy. J Heart Lung Transplant 2000; 19:496–503.
Aziz S, Soine LA, Lewis SL, et al. Donor left ventricular hypertrophy increases risk for early graft failure. Transpl Int 1997; 10:446–450.
Zaroff JG, Babcock WD, Shiboski SC, Solinger LL, Rosengard BR. Temporal changes in left ventricular systolic function in heart donors: results of serial echocardiography. J Heart Lung Transplant 2003; 22:383–388.
Saito S, Matsumiya G, Ueno T, et al. Bench replacement of donor aortic valve before orthotopic heart transplantation. J Heart Lung Transplant 2009; 28:981–983.
Wartig M, Tesan S, Gäbel J, et al. Tricuspid regurgitation influences outcome after heart transplantation. J Heart Lung Transplant 2014; 33:829–835.
Marelli D, Esmailian F, Wong SY, et al. Tricuspid valve regurgitation after heart transplantation. J Thorac Cardiovasc Surg 2009; 137:1557–1559.
Park KY, Park CH, Chun YB, Shin MS, Lee KC. Bicaval anastomosis reduces tricuspid regurgitation after heart transplantation. Asian Cardiovasc Thorac Ann 2005; 13:251–254.
Koch A, Remppis A, Dengler TJ, Schnabel PA, Hagl S, Sack FU. Influence of different implantation techniques on AV valve competence after orthotopic heart transplantation. Eur J Cardiothorac Surg 2005; 28:717–723.
Schnoor M, Schäfer T, Lühmann D, Sievers HH. Bicaval versus standard technique in orthotopic heart transplantation: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2007; 134:1322–1331.
Williams MJ, Lee MY, DiSalvo TG, et al. Biopsy-induced flail tricuspid leaflet and tricuspid regurgitation following orthotopic cardiac transplantation. Am J Cardiol 1996; 77:1339–1344.
Nguyen V, Cantarovich M, Cecere R, Giannetti N. Tricuspid regurgitation after cardiac transplantation: how many biopsies are too many? J Heart Lung Transplant 2005; 24:227–231.
Greenberg J, Teman NR, Haft JW, et al. Association of donor tricuspid valve repair with outcomes after cardiac transplantation. Ann Thorac Surg 2018; 105:542–547.
Trivedi JR, Cheng A, Ising M, Lenneman A, Birks E, Slaughter MS. Heart transplant survival based on recipient and donor risk scoring: a UNOS database analysis. ASAIO J 2016; 62:297–301.
Isaac D. Primary cardiac graft failure-defining, predicting, preventing. J Heart Lung Transplant 2013; 32:1168–1169.
Grauhan O, Siniawski H, Dandel M, et al. Coronary atherosclerosis of the donor heart--impact on early graft failure. Eur J Cardiothorac Surg 2007; 32:634–638.
Russo MJ, Davies RR, Hong KN, et al. Matching high-risk recipients with marginal donor hearts is a clinically effective strategy. Ann Thorac Surg 2009; 87:1066–1071.

Auteurs

Antonio Piperata (A)

Department of Cardiac, Thoracic, Vascular, and Public Health Sciences, University of Padua, Padova.

Raphael Caraffa (R)

Department of Cardiac, Thoracic, Vascular, and Public Health Sciences, University of Padua, Padova.

Olimpia Bifulco (O)

Department of Cardiac, Thoracic, Vascular, and Public Health Sciences, University of Padua, Padova.

Martina Avesani (M)

Department of Cardiac, Thoracic, Vascular, and Public Health Sciences, University of Padua, Padova.

Anna Apostolo (A)

Cardiological Unit, Monzino Hospital, University of Milan, Milan, Italy.

Gino Gerosa (G)

Department of Cardiac, Thoracic, Vascular, and Public Health Sciences, University of Padua, Padova.

Tomaso Bottio (T)

Department of Cardiac, Thoracic, Vascular, and Public Health Sciences, University of Padua, Padova.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH